We are live on
!
Find out more
Kiniksa Pharmaceuticals
KNSA
KNSA
96 hedge funds and large institutions have $539M invested in Kiniksa Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 48 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
271% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 7
243% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 14
97% more capital invested
Capital invested by funds: $274M → $539M (+$265M)
25% more funds holding
Funds holding: 77 → 96 (+19)
23% more call options, than puts
Call options by funds: $1.04M | Put options by funds: $848K
2.55% less ownership
Funds ownership: 86.76% → 84.21% (-2.6%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
96
Holders Change
+19
Holders Change %
+24.68%
% of All Funds
1.97%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
26
Increased
48
Reduced
14
Closed
7
Calls
$1.04M
Puts
$848K
Net Calls
+$194K
Net Calls Change
+$194K
Top Buyers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$17.5M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$12.6M |
| 3 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
+$11.4M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.7M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
+$8.2M |
Top Sellers
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$19.7M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$6.91M |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$2.36M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$1.31M |
| 5 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
-$1.01M |
